M&C Saatchi (SAA)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 112.00 |
|---|---|
| 52-week range | 100.50 – 152.00 |
| Return, 1 month / 3 months | −7.4% / −18.2% |
| Return, 1 year / 3 years | −12.2% / −7.4% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -25.7% |
| Average daily value traded | 18.78M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
M&C Saatchi is an advertising and marketing services group based in London. It works with corporate clients on advertising campaigns, brand strategy, media planning, digital marketing, customer relationship management and consultancy. The company operates through a network of agencies in several countries, serving clients across sectors such as consumer goods, retail, financial services and government. Its work spans creative development, communications planning and specialist marketing services delivered by teams within the group.
M&C Saatchi trades under the code SAA on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
M&C Saatchi (SAA) trades on the London Stock Exchange in UK. It last closed at GBX 112.00 on 27 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,208 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.2% and over the last three months it fell 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.8% | ||
| From 52-week high | -25.3% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.2% | ||
| 6-month return | -12.2% | ||
| 12-month return, skipping the last month | -5.1% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.7% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 18.78M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −7.4% |
| 3 months | −18.2% |
| 6 months | −12.2% |
| 1 year | −12.2% |
| 3 years | −7.4% |
| 5 years | −27.0% |
Signals
| 50-day / 200-day average | 131.73 / 131.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2025 | GBP 0.0195 |
| 9 May 2024 | GBP 0.0160 |
| 8 Jun 2023 | GBP 0.0150 |
| 24 Oct 2019 | GBP 0.0245 |
| 6 Jun 2019 | GBP 0.0851 |
| 5 Jun 2019 | GBP 6.3416 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.